Singapore, Singapore

Noriko Shimasaki

USPTO Granted Patents = 2 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Noriko Shimasaki's Contributions to Immunotherapy

Introduction: Noriko Shimasaki is an accomplished inventor based in Singapore who has made significant strides in the field of immunotherapy through her innovative research and development. With a focus on engineered Natural Killer (NK) cells, Shimasaki's work aims to enhance the targeting of specific cells, particularly those that are cancerous or affected by infectious diseases.

Latest Patents: Noriko Shimasaki holds two notable patents that exemplify her expertise and commitment to advancing medical technology. The first patent, titled "Immune cells comprising truncated NKG2D chimeric receptors," details engineered NK cells that express a chimeric receptor to improve their targeting capacity. These NK cells are designed to bind specifically to cells expressing natural ligands of NKG2D, leading to effective cytotoxic and cytolytic actions. The second patent, "Truncated NKG2D chimeric receptors and uses thereof in natural killer cell immunotherapy," further expands on the utilization of these engineered NK cells in treating diseases, emphasizing their potential benefits in immunotherapy applications.

Career Highlights: Throughout her career, Noriko Shimasaki has been affiliated with prominent organizations such as Nkarta, Inc. and the National University of Singapore. Her experiences in these institutions have undoubtedly contributed to her vast knowledge and skill in the field of immunotherapy and cell engineering.

Collaborations: During her career, Shimasaki has collaborated with distinguished professionals such as Jun Hao Leong and See Voon Seow. These partnerships have facilitated the exchange of ideas and advancements in the realm of Natural Killer cell research, fostering a collaborative environment conducive to innovation.

Conclusion: Noriko Shimasaki’s contributions to immunotherapy through her patented inventions have the potential to greatly impact the treatment of cancer and infectious diseases. Her work exemplifies the critical role of inventors in advancing healthcare solutions and highlights the importance of collaboration in driving innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…